Request Appointment
2501 N Orange AveSuite 689Orlando, FL 32804
Overview of Dr. Mekhail
Dr. Tarek Mekhail is an oncologist in Orlando, FL and is affiliated with multiple hospitals in the area, including AdventHealth Orlando, AdventHealth Waterman, and Orlando Health Orlando Regional Medical Center. He received his medical degree from Other and has been in practice 33 years. Dr. Mekhail accepts several types of health insurance, listed below. He is one of 13 doctors at AdventHealth Waterman and one of 71 doctors at Orlando Health Orlando Regional Medical Center who specialize in Oncology. He has more than 100 publications and over 500 citings.
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 1999 - 2002- Cleveland Clinic FoundationResidency, Internal Medicine, 1995 - 1998
OtherClass of 1984
Cairo University School of MedicineClass of 1984
Certifications & Licensure
FL State Medical License 2008 - 2027
OH State Medical License 1998 - 2010
IA State Medical License 1997 - 1999
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification Cerner Patient Portal and Powerchart, Cerner Corporation, 2015-2016
- CMS Meaningful Use Stage 1 Certification HealtheLife and PowerChart, Cerner Corporation, 2015-2016
- CMS Meaningful Use Stage 1 Certification FirstNet (Image Results), Cerner Corporation, 2015-2016
Clinical Trials
- Lenalidomide, Docetaxel, and Carboplatin in Treating Patients With Advanced Solid Tumors Start of enrollment: 2004 Aug 01
- Acute Venous Thrombosis: Thrombus Removal With Adjunctive Catheter-Directed Thrombolysis Start of enrollment: 2009 Nov 01
- A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib
Publications & Presentations
PubMed
- Patient preferences for EGFR mutation-targeted therapies in non-small cell lung cancer, with a focus on Exon 20 insertions.Jaein Seo, Eileen Curran, Jennifer A Whitty, Marcia K Horn, Tarek Mekhail
Lung Cancer. 2025-11-01 - Brief Report: Phase II Clinical Trial of Atezolizumab in Advanced Nonsmall Cell Lung Cancer Patients Previously Treated With PD-1-Directed Therapy.Dylan Fortman, Hong Wang, Robert VanderWeele, Terry Evans, James G Herman
Clinical Lung Cancer. 2025-01-01 - 5 citationsSinonasal squamous cell carcinoma in the United States: Temporal and geographic patterns associated with HPV testing and positivity.Andrea Costantino, Bruce Haughey, Jianbin Zhu, Tarek Mekhail, Shravan Kandula
Oral Oncology. 2024-07-01
Journal Articles
- Overall Survival with Durvalumab After Chemoradiotherapy in Stage III NSCLCDavid R Spigel, Davey Daniel, Jhanelle E Gray, Augusto Villegas, Tarek Mekhail, Alberto Chiappori, The New England Journal of Medicine
Press Mentions
2024 Finest Doctors Share Their Memorable MomentsDecember 1st, 2024
FHCI to Host Oncology UpdateJune 26th, 2011
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
Altius Provider Directory
AvMed Health Open Access
BCBS Blue Card PPO
BCBS Florida BlueCare HMO
BCBS Florida NetworkBlue
BCBS Florida Preferred Patient Care PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOCoventry Florida - Employer Group PPO
First Health PPO
Great West PPO
Humana ChoiceCare Network PPO
Medical Mutual of Ohio SuperMed Plus
Medical Mutual of Ohio SuperMed POS
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
